Table 5.
Late treatment toxicities and frequency of the most severe complications in SCRT (group I) and LCRT (group II)
| Toxicity | Group | Highest grade of late toxicity |
||
|---|---|---|---|---|
| 1 | 2 | 3 | ||
| Proctitis | I | 13 (39.4) | 9 (27.3) | - |
| II | 9 (33.3) | 4 (14.8) | 1 (3.7) | |
| Fistula | I | - | - | 1 (3.0) |
| II | - | 1 (3.7) | - | |
| Renal failure | I | - | - | - |
| II | - | 1 (3.7) | - | |
| Fibrosis/stenosis | I | - | - | 1 (3.0) |
| II | - | - | 1 (3.7) | |
| Small bowel obstruction | I | - | 1 (3.0) | - |
| II | - | 1 (3.7) | - | |
| Dermatitis | I | - | - | - |
| II | - | - | 1 | |
Values are presented as number (%).
SCRT, short-course chemoradiotherapy; LCRT, long-course chemoradiotherapy.